Ora Biomedical, Inc.
The AI engine Fit Assessment
BetaOra Biomedical, Inc. is a pharmaceutical company focused on discovering and developing small molecule therapeutics that target biological aging and age-related diseases. They utilize a high-throughput drug discovery platform, WormBot-AI, to identify interventions that promote healthy aging.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
- 6m headcount growth: 200%
- 1Y headcount growth: 200%
Ora Biomedical, Inc. is a new pharmaceutical company launched out of the Kaeberlein Lab at the University of Washington. We built a high-throughput small molecule discovery platform to identify longevity interventions, including natural products, pharmaceuticals, and small molecule combinations at a previously unimagined scale. The foundation of our platform is the WormBot-AI, a robotic system coupled with AI-powered analytics to perform phenotype-based screens in live animals. The WormBot-AI is robust, stable, scalable, and already in use identifying novel interventions and aging targets. Ora Biomedical holds the exclusive commercial use rights to the WormBot platform and AI software.